Management of prolactinoma prior to, during, and after pregnancy

被引：0
作者：
Petersenn, Stephan [1 ]
机构：
[1] Erik Blumenfeld Pl 27A, D-22587 Hamburg, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2023年 / 148卷 / 07期
关键词：
hyperprolactinemia; pituitary adenoma; prolactin; dopamine agonist; PITUITARY-ADENOMAS; HYPERPROLACTINEMIA; CABERGOLINE; WITHDRAWAL; DIAGNOSIS;
D O I：
10.1055/a-1847-2500
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hyperprolactinemia should actively be investigated as a potential reason of infertility. Underlying prolactinomas may successfully be treated with dopamine agonists. However, patients with micro- or well-circumscribed macroprolactinomas (Knosp 0 or 1) should also be informed about transsphenoidal surgery offering cure in contrast to long-lasting medical therapy. Management prior to and during pregnancy is usually unremarkable but may pose some specific challenges.
引用
收藏
页码：371 / 379
页数：9
相关论文
共 21 条
  • [1] Radiographic and Hormonal Regression in Prolactinomas: An Analysis of Treatment Failure
    Akinduro, Oluwaseun O.
    Lu, Victor M.
    Izzo, Alessandro
    De Biase, Gaetano
    Vilanilam, George
    Van Gompel, Jamie J.
    Bernet, Victor
    Donaldson, Angela
    Olomu, Osarenoma
    Meyer, Fredric B.
    Quinones-Hinojosa, Alfredo
    Chaichana, Kaisorn L.
    [J]. WORLD NEUROSURGERY, 2019, 129 : E686 - E694
  • [2] A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas
    Anna, B. G. Sant
    Musolino, N. R. C.
    Gadelha, M. R.
    Marques, C.
    Castro, M.
    Elias, P. C. L.
    Vilar, L.
    Lyra, R.
    Martins, M. R. A.
    Quidute, A. R. P.
    Abucham, J.
    Nazato, D.
    Garmes, H. M.
    Fontana, M. L. C.
    Boguszewski, C. L.
    Bueno, C. B.
    Czepielewski, M. A.
    Portes, E. S.
    Nunes-Nogueira, V. S.
    A Ribeiro-Oliveira, Jr.
    Francisco, R. P., V
    Bronstein, M. D.
    Glezer, A.
    [J]. PITUITARY, 2020, 23 (02) : 120 - 128
  • [3] Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size
    Burke, William T.
    Penn, David L.
    Castlen, Joseph P.
    Donoho, Daniel A.
    Repetti, Caroline S.
    Iuliano, Sherry
    Barkhoudarian, Garni
    Laws, Edward R., Jr.
    [J]. JOURNAL OF NEUROSURGERY, 2020, 133 (02) : 321 - 328
  • [4] The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new
    Chanson, Philippe
    Maiter, Dominique
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 33 (02)
  • [5] De Sousa SMC., 2020, J Clin Endocrinol Metab, V105, pdgz076105
  • [6] Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
    Dekkers, Olaf M.
    Lagro, Joep
    Burman, Pia
    Jorgensen, Jens Otto
    Romijn, Johannes A.
    Pereira, Alberto M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01) : 43 - 51
  • [7] Outcomes of Transsphenoidal Microsurgery for Prolactinomas - A Contemporary Series of 162 Cases
    Giese, Sabrina
    Nasi-Kordhishti, Isabella
    Honegger, Juergen
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2021, 129 (03) : 163 - 171
  • [8] Advances in the treatment of prolactinomas
    Gillam, Mary P.
    Molitch, Mark E.
    Lombardi, Gaetano
    Colao, Annamaria
    [J]. ENDOCRINE REVIEWS, 2006, 27 (05) : 485 - 534
  • [9] Prolactinomas: how to handle prior to and during pregnancy?
    Glezer, A. Ndrea
    Bronstein, Marcello D.
    [J]. MINERVA ENDOCRINOLOGICA, 2018, 43 (04) : 423 - 429
  • [10] Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis
    Hu, Jintao
    Zheng, Xin
    Zhang, Weihua
    Yang, Hui
    [J]. PITUITARY, 2015, 18 (05) : 745 - 751
123